3.5. Multivariate Competing Risk Models Analyses Show That CYCLON, NPM1 and R-IPI Are Prognostic Markers of Refractory Disease-Related Death in DLBCL. This evidence concerns the gene NPM1 and diffuse large B-cell lymphoma.